BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 10.24
-0.02 (-0.19%)
Aug 14, 2026, 5:02 PM CET
BioMaxima Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 59.74 | 60.9 | 52.85 | 46.79 | 143.87 | 79.09 | |
Revenue Growth | 5.55% | 15.24% | 12.96% | -67.48% | 81.91% | 29.06% |
Cost of Revenue | 31.06 | 32.45 | 27.79 | 25.11 | 87.86 | 48.94 |
Gross Profit | 28.68 | 28.45 | 25.06 | 21.68 | 56.01 | 30.15 |
Selling, General & Admin | 23.87 | 23.08 | 19.46 | 18.22 | 17.49 | 15.29 |
Other Operating Expenses | 0.32 | 0.56 | 0.96 | 0.95 | 1.67 | -0.39 |
Operating Expenses | 27.96 | 27.35 | 23.79 | 21.61 | 21.11 | 16.49 |
Operating Income | 0.73 | 1.11 | 1.27 | 0.07 | 34.9 | 13.65 |
Interest Expense | -1.12 | -1.19 | -0.98 | -0.61 | -0.48 | -0.2 |
Interest & Investment Income | 0.02 | 0 | 0 | 0.14 | 0.8 | - |
Currency Exchange Gain (Loss) | -0.1 | -0.1 | -0.12 | -0.2 | -0.01 | -0.06 |
Other Non Operating Income (Expenses) | 0.25 | 0.25 | 0.1 | 0.77 | 0.69 | -0.67 |
EBT Excluding Unusual Items | -0.22 | 0.07 | 0.29 | 0.17 | 35.9 | 12.72 |
Gain (Loss) on Sale of Assets | 0.12 | 0.12 | 0.02 | 0.02 | 0 | 0.06 |
Asset Writedown | - | - | - | 0 | -0.03 | - |
Pretax Income | -0.1 | 0.19 | 0.31 | 0.19 | 35.87 | 12.78 |
Income Tax Expense | 0.05 | 0.08 | -0.23 | -0.4 | 6.98 | 2.53 |
Earnings From Continuing Operations | -0.16 | 0.11 | 0.54 | 0.59 | 28.89 | 10.24 |
Net Income | -0.16 | 0.11 | 0.54 | 0.59 | 28.89 | 10.24 |
Net Income to Common | -0.16 | 0.11 | 0.54 | 0.59 | 28.89 | 10.24 |
Net Income Growth | - | -80.37% | -8.70% | -97.97% | 182.00% | 28.86% |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Change | - | - | -2.89% | -3.16% | -0.52% | 4.45% |
EPS (Basic) | -0.04 | 0.03 | 0.13 | 0.14 | 6.68 | 2.37 |
EPS (Diluted) | -0.04 | 0.02 | 0.13 | 0.14 | 6.48 | 2.29 |
EPS Growth | - | -84.33% | -5.99% | -97.91% | 182.97% | 23.78% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.45 | 2.38 | -2.42 | -16.49 | 27.19 | -4.61 |
Free Cash Flow Per Share | 0.11 | 0.57 | -0.58 | -3.82 | 6.10 | -1.03 |
Dividend Per Share | - | - | - | - | 0.500 | 0.450 |
Dividend Growth | - | - | - | - | 11.11% | 80.00% |
Gross Margin | 48.01% | 46.72% | 47.42% | 46.34% | 38.93% | 38.12% |
Operating Margin | 1.22% | 1.82% | 2.41% | 0.14% | 24.26% | 17.26% |
Profit Margin | -0.26% | 0.17% | 1.01% | 1.25% | 20.08% | 12.95% |
Free Cash Flow Margin | 0.76% | 3.90% | -4.58% | -35.24% | 18.90% | -5.83% |
EBITDA | 3.68 | 3.99 | 4.29 | 2.34 | 36.64 | 15.1 |
EBITDA Margin | 6.15% | 6.56% | 8.12% | 5.00% | 25.47% | 19.09% |
D&A For EBITDA | 2.95 | 2.89 | 3.02 | 2.27 | 1.74 | 1.45 |
EBIT | 0.73 | 1.11 | 1.27 | 0.07 | 34.9 | 13.65 |
EBIT Margin | 1.22% | 1.82% | 2.41% | 0.14% | 24.26% | 17.26% |
Effective Tax Rate | - | 44.15% | - | - | 19.47% | 19.82% |